BCRX
BioCryst Pharmaceuticals, Inc.Healthcare$9.02
▲ Bullish
Mkt Cap: $2.26B|Float: 218.2M|SI: 17.2%|DTC: 8.1
Data as of market close Apr 2, 2026
IV Rank
94
IV Pctl
56%
HV 20d
60.0%
52W Range
$6-$11
ATR(14)
$0.63
Exp. Move
±19.1%
P/C Ratio
0.20
Earnings
May 4
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Above
Exp. Move Wide
Low Put/Call
BCRX Key Options Data
- IV Rank
- 93.8%
- Total GEX
- $0.00B
- Total DEX
- $2.5M
- Max Pain
- $10.00
- Expected Move
- ±19.1%
- Put/Call OI
- 0.20
- Net Premium
- $0.7M
- Spot Price
- $9.02
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$1.73 | ±19.1% | $7.30 | $10.75 |
| 2026-05-15 | 43 | ±$1.77 | ±19.7% | $7.25 | $10.80 |
| 2026-06-18 | 77 | ±$2.12 | ±23.6% | $6.90 | $11.15 |
| 2026-09-18 | 169 | ±$3.20 | ±35.5% | $5.82 | $12.22 |
| 2027-01-15 | 288 | ±$3.67 | ±40.7% | $5.35 | $12.70 |
Explore BCRX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.